Liposome Characterization Services

A liposome is a bilayer vesicle with an aqueous core, and its behaviour is set by three things: its size and charge, which lipids form the bilayer, and how much payload is inside. All three are measured on one sample set, so the values describe one preparation rather than three. Each attribute is reported with its technique and conditions, because a size or charge value means little without them.

What we characterize: mean diameter and distribution width, surface charge, lamellarity where required, phospholipid and sterol composition, component ratios, encapsulation efficiency, drug loading, free payload, and the hydrolysis products that accumulate in storage

Technology: light scattering for size and charge, HPLC with UV, CAD, or ELSD detection for separation of free and encapsulated payload, and LC-MS/MS for lipid composition and degradation products

Reporting options: diameter with distribution, zeta potential with medium and pH, component ratios, encapsulated fraction, payload per unit lipid, and degradation product levels against a stored baseline

Request Analysis

Submit Your Request Now

×

Our services have earned the trust of companies, schools, and organizations globally, and we remain dedicated to maintaining that trust.

Boston University
University at Buffalo
UMass Medical School
Hawaii Pacific University
Medizinische Fakultät
Louisiana State University
NYU Langone
Nature's Fynd
Dietary supplement manufacturer
  • Service We Provide
  • Characterization Panel
  • Degradation Signature
  • Applications
  • Advantages
  • Workflow
  • Results and Data Analysis
  • Sample Requirements
  • FAQ

What Liposome Characterization Covers and Why Composition Drives Function

A liposomal formulation is defined by its critical quality attributes rather than by one number, and those attributes are linked: the lipid composition sets how the bilayer behaves, the bilayer sets what leaks, and what leaks sets the release profile. Characterization therefore works best as a connected set of measurements on one preparation, and composition is where lipid analysis contributes most, because a shifted ratio or a hydrolysis product appears before size or release moves.

Liposomes and Lipid Nanoparticles Are Characterized Differently

Liposomes and lipid nanoparticles are both lipid-based carriers, but they are different objects and they are not characterized the same way. A liposome encloses an aqueous core inside a bilayer, so encapsulation and release are measured across a membrane. A lipid nanoparticle is a solid lipid core that complexes nucleic acid electrostatically, so the useful measures are the component ratio and the fraction of cargo left unbound.

Studies built around the nucleic acid carrier are served by our lipid nanoparticle route, while the routes on this page are built for vesicles with an aqueous interior.

Liposome Characterization Services in Creative Proteomics

The routes below address different attributes of the same preparation. They can be run as a set or chosen individually, and the choice usually follows from which attribute the development decision depends on.

Size, Polydispersity, and Surface Charge

Measure the mean diameter, the distribution width, and the surface charge of a preparation, with the measurement conditions stated so that values from different batches, or from different laboratories, can be placed side by side.

Lipid Composition and Component Ratios

Quantify the phospholipids and the sterol in the bilayer by LC-MS and report them as relative amounts, so that the intended formulation can be compared with what the preparation actually contains.

Encapsulation Efficiency and Drug Loading

Separate encapsulated from free payload and quantify both, expressing the result as the encapsulated fraction and as the payload amount per unit of lipid, because those two figures answer different development questions.

Free Payload and Leakage Measurement

Quantify the payload that has left the vesicle in a stored or stressed sample, which is the measurement that separates a release experiment from a stability observation.

Lysolipid and Hydrolysis Product Analysis

Measure the lysophospholipids and free fatty acids formed when an ester bond in the bilayer hydrolyses, giving a chemical readout of degradation that a size measurement on its own will not show.

Comparison Across Batches and Process Variants

Run the same measurement set on process variants, storage time points, or a test preparation against a reference, so a difference is attributed to a defined attribute rather than to the formulation as a whole.

What Is Characterized in a Liposomal Formulation

Three attribute groups cover most development questions, and each one is reported with the conditions that produced it. The tables below list what is measured in each group and how the value is expressed.

  • Size and Surface
  • Lipid Composition
  • Encapsulation

Size, Surface Charge, and Lamellarity

These attributes describe the physical state of the dispersion, and each one depends on the medium in which it is measured, so the conditions are reported with the value.

Attribute What It Indicates How It Is Reported
Mean particle diameter Where the vesicle sits in the size range that governs distribution and retention behaviour Mean diameter together with the distribution width, and the technique and measurement conditions stated
Polydispersity Whether the preparation is one population or a mixture of populations Distribution profile or polydispersity value, with the basis on which it was derived recorded
Surface charge Whether vesicles repel each other or aggregate, and how they will interact with a surface Zeta potential with the medium composition and pH, because the value shifts with both
Lamellarity and morphology How many bilayers enclose the core, which sets the internal volume available to the payload Reported where the development question depends on it, with the method named and the limitation stated

Lipid Composition and Component Ratios

The bilayer is a defined mixture, so its composition is reported as relative amounts and as the ratio between components, both from one extraction.

Component Why It Matters Reported As
Phospholipid classes Set the phase behaviour of the bilayer and the temperature at which it changes state Relative amount per class, measured in the same extraction as the sterol
Sterol content Modulates permeability and mechanical stability, and its effect depends on how much is present Relative amount, with the sterol species identified because plant and animal sources differ
Lysophospholipids Enter as an impurity in the raw lipid or form during processing and storage, and destabilize the bilayer Relative amount per species, reported as a degradation indicator rather than as a formulation component
Component ratios A formulation is defined as a ratio, so the ratio is the figure that can be compared across batches Ratio of the components stated in the intended formulation, with the calculation shown

Where the bilayer phospholipids need to be reported as a full profile rather than as a ratio, the measurement is planned with our phosphatidylcholine analysis, phosphatidylethanolamine analysis, and phosphatidylglycerol analysis routes, and the sterol side is covered with cholesterol analysis so that every component value comes from one preparation.

Encapsulation, Free Payload, and Release

Encapsulation is only as reliable as the separation behind it, so the separation method is named in the report rather than left implicit.

Parameter Definition Measurement Basis
Encapsulation efficiency Share of the total payload held inside the vesicles at the time of sampling Measured after separating encapsulated from free payload, with the separation method named
Drug loading Payload amount relative to the amount of lipid present Calculated from the encapsulated amount and the lipid content measured in the same preparation
Free payload Payload remaining outside the vesicles at the time of sampling Measured directly in the separated free fraction rather than obtained by subtraction
Release profile Change in free payload over time under defined conditions Measured at defined time points, with the medium, temperature, and separation method recorded

The three attribute groups are reported against one sample identifier, which is what allows a composition result and a size result to be read as statements about the same preparation rather than as two unrelated measurements.

The Degradation Signature of a Liposomal Formulation

A liposome carries a record of what has happened to it, and that record is chemical. The ester bond between the glycerol backbone and an acyl chain hydrolyses slowly during storage, releasing a lysophospholipid and a free fatty acid; the reaction runs faster at elevated temperature, at pH extremes, and in the presence of payloads that catalyse it.

Because the loss happens one acyl chain at a time, the parent lipid generally stays in the bilayer, so the vesicle diameter can barely move while the lysophospholipid level is already climbing.

Degradation Product Formed From Analytical Consequence Why a Size Measurement Will Not Show It
Lysophospholipid Hydrolysis of one acyl chain from a diacyl phospholipid More polar than its parent, so it separates early under reversed-phase conditions and needs its own standard The parent lipid stays in the bilayer, so the diameter of the vesicle changes little at first
Free fatty acid The acyl chain released by the same hydrolysis, or by oxidation of an unsaturated chain Measured as the free acid, which is a different analyte from the esterified form quantified in a composition panel The released chain moves into the surrounding medium rather than changing the particle
Oxidized phospholipid Oxygenation of an unsaturated acyl chain that remains in the bilayer Requires its own method and its own standards, and is reported as a species rather than as a total A chemical change can take place with no measurable change in particle size

Two consequences follow for how a stability study is planned. First, composition and degradation markers are measured on the same time points as the physical attributes, so a finding can be attributed to a chemical change rather than to a physical one. Second, the raw lipid is profiled before preparation where the question concerns a starting material, because a lysophospholipid present on day zero did not form in the formulation.

The same logic applies to sphingolipid components, whose deacylated forms are measured beside the parent through our lysophosphatidylcholine analysis and sphingomyelin analysis routes.

Liposome bilayer hydrolysis, lysolipid formation, and payload leakageLiposome Degradation and Leakage Routes: a bilayer vesicle with an aqueous core, hydrolysis of one acyl chain from a bilayer phospholipid producing a lysophospholipid and a free fatty acid, oxidation of an unsaturated acyl chain that remains esterified, and the payload leaving through the bilayer as the packing order changes.

Where Liposome Characterization Is Used

Projects reaching this service differ in the attribute the decision depends on, and in whether the comparison is against a specification, a reference preparation, or an earlier time point. Designs outside the patterns below are adapted during feasibility review.

Formulation and Process Development

Compare preparations made with different lipid ratios, payloads, or processing steps, using size, charge, composition, and encapsulation together so that a performance difference can be traced to a specific attribute instead of the process as a whole.

Forced Degradation and Stability Studies

Follow how composition and the level of hydrolysis products change across storage time points and stressed conditions, which is where a bilayer problem becomes visible before it appears as a change in particle size or release.

Comparison Across Batches and Processes

Assess whether two preparations are interchangeable on the attributes that matter, by running one measurement set on both and reporting the pairs on one table, so the difference is quantified rather than described.

Payload Release and Retention Research

Establish how much payload is retained and how much is free at defined time points, which supports formulation ranking in research settings and helps distinguish a formulation that leaks from one that was loaded poorly.

Why Choose Our Liposome Characterization Platform

  • Attributes measured on one preparation: Size, charge, composition, and encapsulation are reported against a single sample identifier, so the values describe the same material rather than three separately aliquoted samples.
  • Composition reported as a ratio: Phospholipid classes and sterol are returned as relative amounts and as the component ratio, which is the form in which a formulation is defined and the form that can be compared across batches.
  • Degradation markers included by design: Lysophospholipids, free fatty acids, and oxidized species are part of the standard measurement set, because a bilayer can change chemically while the particle size stays inside its expected range.
  • Separations named, not assumed: The method used to separate free from encapsulated payload is stated in the report, since an encapsulation figure is only as sound as the separation behind it.
  • Conditions attached to physical values: Diameter and zeta potential are reported with the medium, temperature, and pH, so a number can be compared with data generated elsewhere without guessing the context.
  • Raw material checked separately: Where the question concerns a starting lipid, it is characterized before preparation so that an impurity already present is not later read as something the formulation produced.

Liposome Characterization Workflow

Liposome characterization workflow from attribute selection to reportingFive-step liposome characterization workflow: review of the development question and the attribute it depends on, sample preparation and separation of free from encapsulated payload, physical measurement of size and surface charge, lipid composition and degradation analysis by chromatography and mass spectrometry, and reporting of all attributes against one sample identifier.

The workflow is modular, and one decision shapes it: whether the question concerns the physical state of the dispersion, the chemical state of the bilayer, or the payload. A process comparison usually needs the physical attributes and the ratio; a stability question needs the chemical side, including the hydrolysis products; a loading question needs the separation and the free fraction. Fixing that first decides which sample preparation is used, because a preparation optimized for light scattering is not the one used for lipid extraction.

Platforms Used for Liposome Characterization

Thermo Scientific UltiMate 3000

Thermo Scientific UltiMate 3000 (Figure from Thermo Fisher) — separation of free from encapsulated payload and quantification of lipid components

SCIEX Triple Quad 6500+

SCIEX Triple Quad 6500+ (Figure from SCIEX) — scheduled MRM for phospholipid classes, sterol, and hydrolysis products

Method Specifications for Liposome Characterization

Parameter Specification
Dilution and medium for size Samples diluted into a defined medium at a stated pH and temperature, because dilution changes the measured diameter and the surface charge together
Light scattering Dynamic light scattering for the size distribution and electrophoretic light scattering for surface charge, with the same sample handled under both conditions where possible
Lipid extraction Matrix-specific extraction from the vesicle suspension, with an internal standard added before extraction so that recovery is measured rather than assumed
LC separation Reversed-phase or hydrophilic interaction separation depending on whether the target is a phospholipid class, a lysophospholipid, or a sterol
Detection Mass spectrometry for species-level composition and hydrolysis products; charged aerosol or evaporative light scattering detection where class-level amounts are sufficient
Encapsulation separation Size exclusion, dialysis, or an equivalent validated separation, chosen according to the payload and named in the report
Release conditions Medium, temperature, and time points defined with the study, and the same separation applied at every time point so the profile is internally consistent
Degradation markers Lysophospholipids and free fatty acids measured against a baseline sample from the same preparation, rather than against a fixed reference value
Reporting basis Absolute amount, relative amount, or ratio, with the conditions, the separation method, and the internal standard stated for every value

Results and Data Analysis

Liposome Characterization Report

The core report places the physical attributes, the lipid composition, and the payload results on one structure, so that a formulation can be read as a whole rather than attribute by attribute.

Key Features:

  • Diameter, distribution, and surface charge reported with the medium, temperature, and pH at which they were measured
  • Phospholipid classes and sterol given as relative amounts and as the component ratio, with the calculation shown
  • Encapsulation efficiency, drug loading, and free payload reported separately, with the separation method named
  • A quality control summary covering calibration performance, blank observations, replicate agreement, and any value qualified for falling outside the calibrated range

Raw instrument files can be discussed during project planning when they are needed for archiving or independent review.

Phospholipid composition and lysophospholipid level across storage time points

Phospholipid composition and lysophospholipid level plotted across storage time points, showing the chemical change that precedes a shift in particle size.

Encapsulated and free payload with the corresponding release profile

Encapsulated and free payload measured at each time point, with the release profile calculated from the separated fractions rather than by subtraction.

Composition and Ratio Report

Where the decision concerns the bilayer itself, the deliverable is a composition table built so that it can be placed directly beside the intended formulation.

Key Features:

  • Phospholipid classes, sterol, and lysophospholipids reported as relative amounts from one extraction
  • Component ratio calculated from those values, with the intended ratio shown alongside for direct comparison
  • Raw lipid material characterized separately where the question concerns what was present before preparation

Payload and Release Report

Encapsulation figures depend entirely on how free payload was separated from encapsulated payload, so that step is part of the reported result.

Key Features:

  • Encapsulated, free, and total payload reported individually, each measured directly rather than derived by subtraction
  • Drug loading expressed against the lipid content measured in the same preparation
  • Release profile at defined time points, with the medium, temperature, and separation method stated for every point

Sample Requirements for Liposome Characterization

Sample Type Collection and Handling Typical Starting Amount Planning Notes
Liposomal suspension Ship at the storage temperature used for the study, without freezing unless the formulation tolerates it, and record the time since preparation 1 millilitre or more at the working concentration State the intended composition and payload so that measured values can be compared with the design rather than in isolation
Lyophilized or frozen preparation Provide both the pre-lyophilization material and the reconstituted form where the question concerns the process Two aliquots of the same batch Reconstitution changes the dispersion state, so the medium and the reconstitution protocol are recorded
Process intermediates Keep each step cold and process promptly, since a size distribution continues to evolve after the step is complete 0.5 millilitres or more per step Sampling at the step itself is what allows a difference in the final material to be attributed to a defined operation
Raw lipid or excipient material Store sealed and protected from oxygen, light, and heat, and record the lot and the supplier 5 to 20 milligrams Characterizing the starting material separately is what distinguishes an impurity already present from one formed during processing
Stored or stressed samples Provide the time point and the stress condition for each sample, and store unopened until analysis 0.5 millilitres or more per time point Time points from the same batch are compared against each other, so the day-zero sample is part of the set rather than a separate request
Payload reference solution Provide the free payload as a solution at a known concentration, stored as the compound requires 100 microlitres or more A free payload reference is what allows the separated free fraction to be quantified against a standard rather than estimated

The amounts above are planning figures. Final quantities are confirmed once the attribute set has been agreed, because a composition-only project and a full characterization set including release measurement do not carry the same requirement.

Frequently Asked Questions About Liposome Characterization

Can size, composition, and encapsulation be measured on the same sample?

Yes, and it is the preferred arrangement. The dispersion is subsampled for the physical measurements, then a separate subsample is taken for lipid extraction and for the separation of free from encapsulated payload. All results are reported against one sample identifier, so a composition finding and a size finding can be read as statements about the same material. The one caveat is that dilution for light scattering changes the medium, so the physical measurements are taken from a defined dilution and that dilution is recorded in the report.

How is free payload separated from encapsulated payload?

By size exclusion, dialysis, or an equivalent validated separation, chosen according to the payload and the formulation. What matters more than the choice is that the same separation is applied to the standard, the sample, and every time point, and that it is named in the report. Separation methods differ in whether they perturb the vesicles, so a figure obtained by one method is not automatically comparable with a figure obtained by another, and the free fraction is measured directly rather than calculated by subtracting the encapsulated amount from a total.

Which degradation products can be detected in a stored liposome?

Three groups are covered routinely. Lysophospholipids form when one acyl chain is hydrolysed away from a diacyl phospholipid, and they are more polar than their parent so they separate early. Free fatty acids appear from the same hydrolysis or from oxidation of an unsaturated chain, and they are a different analyte from the esterified form measured in a composition panel. Oxidized phospholipids form when an unsaturated chain inside the bilayer is oxygenated, which needs its own method and its own standards. All three are reported against a day-zero sample from the same batch rather than against a fixed reference value.

Can the measurement tell a formulation change from a storage change?

Only if the design separates them, and that is arranged at planning. A formulation comparison needs process variants or composition variants measured at one time point, with the raw lipid characterized separately so an impurity present from the start is not attributed to the formulation. A storage study needs several time points from one batch, including day zero, with the physical attributes and the degradation markers measured on the same time points. When both questions are present, they are run as two arms rather than pooled into one comparison.

How much sample is needed?

As a planning figure, around 1 millilitre of suspension at the working concentration supports the physical attributes plus lipid composition, and each additional time point or process step is sampled separately at roughly 0.5 millilitres. Raw lipid material needs 5 to 20 milligrams, and a free payload reference of about 100 microlitres allows the free fraction to be quantified against a standard. Final quantities are confirmed once the attribute set is agreed, because a composition-only project and a full set including release measurement do not carry the same requirement.

Is this service for clinical diagnostic use?

No. This service is for research use only. It is not intended for clinical diagnostic procedures, patient management, or treatment decisions, and no result is reported as a clinical index. Measurements intended for clinical interpretation are performed by licensed clinical laboratories. If your study involves samples that may require clinical follow-up, please indicate this during study design.

What information is needed for a quote?

Provide the formulation as designed, including the intended lipid components and their ratio, the payload, and the preparation method. Add the attribute set the decision depends on, the number of preparations and replicates, the time points if the study is longitudinal, the storage history of the material, and the volume available. Mention the comparison the data has to support, since a process comparison and a stability finding need different sample arms and are quoted accordingly.

References

  1. Fan, Y., Marioli, M., & Zhang, K. "Analytical characterization of liposomes and other lipid nanoparticles for drug delivery." Journal of Pharmaceutical and Biomedical Analysis 192, 113642 (2021). https://doi.org/10.1016/j.jpba.2020.113642
  2. Franz, A. H., Samoshina, N. M., & Samoshin, V. V. "A convenient method for the relative and absolute quantification of lipid components in liposomes by 1H- and 31P NMR-spectroscopy." Chemistry and Physics of Lipids 261, 105395 (2024). https://doi.org/10.1016/j.chemphyslip.2024.105395
  3. Siriwardane, D. A., Wang, C., Jiang, W., & Mudalige, T. "Quantification of phospholipid degradation products in liposomal pharmaceutical formulations by ultra performance liquid chromatography-mass spectrometry (UPLC-MS)." International Journal of Pharmaceutics 578, 119077 (2020). https://doi.org/10.1016/j.ijpharm.2020.119077
  4. Hara, S., Arase, S., Sano, S., et al. "Anion exchange-HPLC method for evaluating the encapsulation efficiency of mRNA-loaded lipid nanoparticles using analytical quality by design." Journal of Chromatography B 1247, 124317 (2024). https://doi.org/10.1016/j.jchromb.2024.124317
  5. Lu, B., Ma, Q., Zhang, J., et al. "Preparation and characterization of bupivacaine multivesicular liposome: A QbD study about the effects of formulation and process on critical quality attributes." International Journal of Pharmaceutics 598, 120335 (2021). https://doi.org/10.1016/j.ijpharm.2021.120335
  6. Nasr, G., Greige-Gerges, H., Elaissari, A., & Khreich, N. "Liposome Permeability to Essential Oil Components: A Focus on Cholesterol Content." Journal of Membrane Biology 254(4), 381–395 (2021). https://doi.org/10.1007/s00232-021-00180-3
  7. Sætern, A. M., Skar, M., Braaten, A., & Brandl, M. "Camptothecin-catalyzed phospholipid hydrolysis in liposomes." International Journal of Pharmaceutics 288(1), 73–80 (2005). https://doi.org/10.1016/j.ijpharm.2004.09.010
* Our services can only be used for research purposes and Not for clinical use.

Applications:


Online Inquiry

CONTACT US

  • USA
  • Tel: 1-631-275-3058 (USA)
  • Address: SUITE 115, 17 Ramsey Road, Shirley, NY 11967, USA
  • Email:
  • Fax: 1-631-614-7828
  • Germany
  • Address: 65830 Kriftel, Gutenbergstraße 5. Frankfurt am Main, Germany
Copyright © 2026 Creative Proteomics. All rights reserved.